INMB · Inmune Bio, Inc. · Fails to Deliver
$0.89
0.00 (-0.47%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20
7246
Avg daily vol (3M)
342.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-23 | 474 | $1.54 | $730 |
| 2026-10-05 | 2,202 | $1.93 | $4,250 |
| 2026-10-02 | 10,253 | $1.93 | $19,788 |
| 2026-09-24 | 2,480 | $2.00 | $4,960 |
| 2026-09-21 | 4,973 | $2.33 | $11,587 |
| 2026-09-17 | 3,573 | $2.05 | $7,325 |
| 2026-09-15 | 520 | $2.33 | $1,212 |
| 2026-09-11 | 1,913 | $2.31 | $4,419 |
| 2026-09-10 | 5,347 | $2.46 | $13,154 |
| 2026-09-09 | 1,374 | $2.51 | $3,449 |
| 2026-08-25 | 4,280 | $2.36 | $10,101 |
| 2026-08-24 | 2,802 | $2.32 | $6,501 |
Showing 1–12 of 12 settlements
Key facts
CIK
1711754
CUSIP
45782T105
13F (30d)
70 filings
58 filers
Visit website
Investor relations